Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Methyl-Seq: Lib prep (MspI;HpaII) for mouse samples causes issues for human samples

    Hello,

    I have a question concerning whole genome enzymatic digestion in preparation for NGS. Currently, we digest mouse tissue and cell line samples, using the standard enzymes MspI and HpaII, as an intermediary step before the actual NGS. The procedure works fine, yet when we wanted to use the same technique on samples of human origin (cell line, tissue or blood), the digestion seems to fail. We are using the same enzyme and buffer batch as for the mouse samples. Yet we do not find back digested fragments for the human samples when doing a size-selection gel, contrary to the digested fragments of the mouse samples that are present. Running the mouse and human samples in parallel, checking the possible interference of reagents used during DNA extraction did not change anything. The conditions of the digestion are the same for both samples, in silico digestion of both genomes seemed fine, and according to literature these enzymes should work for both genomes. Does anyone have any experience/encountered similar problems or has an idea what could be the problem when we shift from mouse to human samples? Thanks for your help!

    Kind Regards

  • #2
    That does not make sense. If you can post an image or electropherogram of sample before or better a mock digest (no enzyme) and after digest someone might be able to help.

    Comment

    Latest Articles

    Collapse

    • seqadmin
      Understanding Genetic Influence on Infectious Disease
      by seqadmin




      During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.

      Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...
      09-09-2024, 10:59 AM
    • seqadmin
      Addressing Off-Target Effects in CRISPR Technologies
      by seqadmin






      The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...
      08-27-2024, 04:44 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by seqadmin, Today, 06:25 AM
    0 responses
    13 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, Yesterday, 01:02 PM
    0 responses
    12 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 09-18-2024, 06:39 AM
    0 responses
    14 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 09-11-2024, 02:44 PM
    0 responses
    14 views
    0 likes
    Last Post seqadmin  
    Working...
    X